GenScript, the world’s largest provider of synthetic genes, has launched a new GenPlus™ Next-Generation Gene Synthesis service, which offers unmatched capacity and cost-efficiency for custom gene synthesis.
GenScript is pleased to announce that it will participate in the Synthetic Yeast Genome Sc2.0 Project, initiated and organized by Dr. Jef Boeke of Johns Hopkins University’s (JHU) School of Medicine.
As a compliment to their successful BacPower™ and MamPower™ packages, GenScript USA Incorporation has launched a new PROTential protein expression evaluation service.